This contract expires in 42 days (Jul 23, 2026).
SHERLOCK BIOSCIENCES, INC. - DEVELOPMENT OF A LOW-COST, POINT-OF-NEED MOLECULAR TEST FOR FLU A+B AND SELF-COLLECTED SWAB SPECIMENS.
Key Details
Description
DEVELOPMENT OF A LOW-COST, POINT-OF-NEED MOLECULAR TEST FOR FLU A+B AND SELF-COLLECTED SWAB SPECIMENS.
Context & Analysis
On Feb 13, 2026, Department of Health and Human Services obligated $2,148,974 to SHERLOCK BIOSCIENCES, INC. for development of a low-cost, point-of-need molecular test for flu a+b and self-collected swab specimens.. The award is classified under NAICS 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) and issued as a cost sharing contract. Competition extent: full and open competition with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in WATERTOWN, MA. The contract is scheduled through Jul 23, 2026 — approximately 1 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541714 — related awards are listed below.
Contractor Information
Similar Awards
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ALLUCENT GOVERNMENT SERVICES (US) LLC
$370.1M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC.
$330.2M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
TECHNICAL RESOURCES INTERNATIONAL, INC.
$317.1M
ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION
PARATEK PHARMACEUTICALS, INC
$265.3M
ASPR-18-04963 -- FUNDING FOR BALOXAVIR MARBOXIL ACTIVITIES FOR BASE PERIOD TASK UNDER THE GENENTECH OTA
GENENTECH INC
$243.7M
Stay Updated
Get notified about new opportunities matching your interests.